Pages that link to "Q34458717"

The following pages link to Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. (Q34458717):

Displaying 40 items.

• The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm (Q26741231) (← links)
• Recent Advances in the Development of Experimental Animal Models Mimicking Human Aortic Aneurysms (Q26798395) (← links)
• Micromanaging abdominal aortic aneurysms (Q26823361) (← links)
• Imaging of small animal peripheral artery disease models: recent advancements and translational potential (Q27009178) (← links)
• Diagnosis and treatment of congenital abdominal aortic aneurysm: a systematic review of reported cases (Q28082651) (← links)
• Murine ultrasound imaging for circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model (Q30451599) (← links)
• Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression. (Q33745936) (← links)
• Effects of anatomical characteristics as factors in abdominal aortic aneurysm rupture: CT aortography analysis (Q33833773) (← links)
• Flow Mediated Dilatation and Progression of Abdominal Aortic Aneurysms (Q33870154) (← links)
• Pharmacological inhibitor of notch signaling stabilizes the progression of small abdominal aortic aneurysm in a mouse model. (Q35114888) (← links)
• Adventitial Tertiary Lymphoid Organs as Potential Source of MicroRNA Biomarkers for Abdominal Aortic Aneurysm (Q35636731) (← links)
• TElmisartan in the management of abDominal aortic aneurYsm (TEDY): The study protocol for a randomized controlled trial (Q35786928) (← links)
• Molecular imaging of aortic aneurysms. (Q36066718) (← links)
• Inhibition of Proteasome Activity by Low-dose Bortezomib Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm in Apo E(-/-) Mice (Q36217025) (← links)
• Diagnostic imaging for spinal disorders in the elderly: a narrative review (Q36222496) (← links)
• Preoperative Predictors of Long-Term Mortality after Elective Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm (Q36727264) (← links)
• Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial (Q37554863) (← links)
• Use of Nanoparticles As Contrast Agents for the Functional and Molecular Imaging of Abdominal Aortic Aneurysm (Q37716747) (← links)
• Proteomics in aortic aneurysm--what have we learnt so far? (Q38106661) (← links)
• Meta-analysis of peak wall stress in ruptured, symptomatic and intact abdominal aortic aneurysms (Q38240698) (← links)
• Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013. (Q38402766) (← links)
• The role of intraluminal thrombus formation for expansion of abdominal aortic aneurysms (Q41725841) (← links)
• Incidental abdominal aneurysms: a retrospective study of 13,115 patients who underwent a computed tomography scan. (Q45253665) (← links)
• Inositol in the MAnaGemENt of abdominal aortic aneurysm (IMAGEN): study protocol for a randomised controlled trial (Q45256495) (← links)
• The Need for Translational Research to Advance Peripheral Artery Disease Management. (Q46085332) (← links)
• Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm. (Q47164996) (← links)
• Effects of acute exercise on endothelial function in patients with abdominal aortic aneurysm. (Q48308141) (← links)
• Biomarkers for AAA: Encouraging steps but clinical relevance still to be delivered (Q48686960) (← links)
• Screening key genes for abdominal aortic aneurysm based on gene expression omnibus dataset (Q50032904) (← links)
• The use of pre-existing CT imaging in screening for abdominal aortic aneurysms. (Q52982684) (← links)
• Abdominal aortic aneurysm screening: concepts and controversies. (Q55330865) (← links)
• Risk of Cardiovascular Disease and Venous Thromboembolism Among Patients With Incident ANCA-Associated Vasculitis: A 20-Year Population-Based Cohort Study (Q56243435) (← links)
• Randomized Placebo-Controlled Trial Assessing the Effect of 24-Week Fenofibrate Therapy on Circulating Markers of Abdominal Aortic Aneurysm: Outcomes From the FAME -2 Trial (Q58123970) (← links)
• VPO1 Modulates Vascular Smooth Muscle Cell Phenotypic Switch by Activating Extracellular Signal-regulated Kinase 1/2 (ERK 1/2) in Abdominal Aortic Aneurysms (Q58127386) (← links)
• Macrophage-derived netrin-1 promotes abdominal aortic aneurysm formation by activating MMP3 in vascular smooth muscle cells (Q59332853) (← links)
• Deficiency of IL12p40 (Interleukin 12 p40) Promotes Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm (Q61442920) (← links)
• Effect of Cyclic Stretch on Vascular Endothelial Cells and Abdominal Aortic Aneurysm (AAA): Role in the Inflammatory Response (Q61795633) (← links)
• MicroRNA‑26a protects vascular smooth muscle cells against H2O2‑induced injury through activation of the PTEN/AKT/mTOR pathway. (Q64998027) (← links)
• Tropoelastin: an in vivo imaging marker of dysfunctional matrix turnover during abdominal aortic dilation (Q91701617) (← links)
• Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm (Q99418643) (← links)